» Articles » PMID: 4628113

Cerebrospinal Fluid Concentrations of Rifampin in Meningeal Tuberculosis

Overview
Specialty Pulmonary Medicine
Date 1972 Sep 1
PMID 4628113
Citations 19
Authors
Affiliations
Soon will be listed here.
Citing Articles

Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis.

Mezochow A, Thakur K, Zentner I, Subbian S, Kagan L, Vinnard C Int J Infect Dis. 2019; 84:15-21.

PMID: 31051278 PMC: 6666413. DOI: 10.1016/j.ijid.2019.04.026.


Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.

Abulfathi A, Decloedt E, Svensson E, Diacon A, Donald P, Reuter H Clin Pharmacokinet. 2019; 58(9):1103-1129.

PMID: 31049868 DOI: 10.1007/s40262-019-00764-2.


Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis.

Dian S, Yunivita V, Ganiem A, Pramaesya T, Chaidir L, Wahyudi K Antimicrob Agents Chemother. 2018; 62(12).

PMID: 30224533 PMC: 6256787. DOI: 10.1128/AAC.01014-18.


Tuberculous Meningitis in Children and Adults: New Insights for an Ancient Foe.

Mezochow A, Thakur K, Vinnard C Curr Neurol Neurosci Rep. 2017; 17(11):85.

PMID: 28932979 PMC: 5729589. DOI: 10.1007/s11910-017-0796-0.


Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Nau R, Sorgel F, Eiffert H Clin Microbiol Rev. 2010; 23(4):858-83.

PMID: 20930076 PMC: 2952976. DOI: 10.1128/CMR.00007-10.